Overview and Scope
Hyperpigmentation disorder treatment refers to the various methods used to reduce the appearance of dark spots or patches on the skin that occur due to excess melanin production. Topical creams containing ingredients such as hydroquinone, vitamin C, and azelaic acid can be used to lighten the skin.
Sizing and Forecast
The hyperpigmentation disorder treatment market size has grown strongly in recent years. It will grow from $5.3 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to clinical trials and research, advances in chemical peels, cultural shift towards skincare, emphasis on non-invasive options, demand for natural products.
The hyperpigmentation disorder treatment market size is expected to see strong growth in the next few years. It will grow to $7.73 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to focus on non-invasive treatments, enhanced skincare awareness, telemedicine and virtual consultations, regulatory support and approvals, personalized treatment options. Major trends in the forecast period include innovative topical formulations, advancements in laser technologies, focus on combination therapies, personalized treatment approaches, rising demand for natural products.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/hyperpigmentation-disorder-treatment-global-market-report
The hyperpigmentation disorder treatment market covered in this report is segmented –
1) By Treatment Type: Cosmeceuticals, Laser Therapy, Chemical Peels, Microdermabrasion, Phototherapy, Other Treatments
2) By Disease Indication: Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines, Other Disease Indications
3) By End-Users: Hospitals, Esthetic Clinics And Dermatology Centers, Other End-Users
North America was the largest region in the hyperpigmentation disorders treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global hyperpigmentation disorder treatment market report during the forecast period. The regions covered in the hyperpigmentation disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=10709&type=smp
Major Driver Impacting Market Growth
Rise in prevalence of pigmentation disorders is expected to drive the growth of the hyperpigmentation disorders treatment market. Pigmentation disorders encompass a range of conditions that impact the coloration of the skin, hair, and eye iris. These disorders arise due to issues with melanin, the pigment produced by melanocytes that plays a role in determining skin, hair, and eye color. Treatment options for hyperpigmentation disorders vary depending on the underlying cause and severity of the condition. Mild cases can often be managed with over-the-counter topical creams containing ingredients like azelaic acid, cysteamine cream, vitamin C, and hydroquinone, which possess skin-lightening properties. For instance, in March 2023, according to the Centers for disease control (CDC) report, a US-based federal agency of health, the incidence of Candida auris (C. auris) cases increased from 476 in 2019 to 1,471 in 2021 in the US and the number of cases being screened tripled between 2020 and 2021, reaching 4,041 in total. Additionally, in December 2022, according to the National Psoriasis Foundation, a US-based nonprofit organization serving people with psoriasis and psoriatic arthritis, Psoriasis affects 125 million people globally, accounting for 2 to 3 percent of the overall population, where it affects approximately 1.5 percent of African Americans compared to 3.6 percent of Caucasians. Therefore, rise in prevalence of pigmentation disorders is expected to proper the growth of the hyperpigmentation disorders treatment market.
Key Industry Players
Major companies operating in the hyperpigmentation disorder treatment market report are Vivier Pharma, Obagi Cosmeceuticals LLC, RXi Pharmaceuticals Corporation, EpiPharm AG, Laboratories Pierre Fabre, SkinCeuticals, Galderma S.A., Allergan PLC., Bayer AG, Lumenis Be Ltd., Aerolase Corporation, Candela Corporation, Cynosure, PCA Skin, Episciences Inc., La Roche-Posay, L’Oréal S.A., Pierre Fabre Laboratories, Alvogen Inc., Clinuvel Pharmaceuticals Ltd., Clarify Medical Inc., Incyte Corporation, Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries, SkinMedica Inc., Neutrogena Corporation, Paula’s Choice Inc., ZO Skin Health Inc., Estée Lauder Companies Inc.
The hyperpigmentation disorder treatment market report table of contents includes:
1. Executive Summary
2. Hyperpigmentation Disorder Treatment Characteristics
3. Hyperpigmentation Disorder Treatment Trends And Strategies
4. Hyperpigmentation Disorder Treatment – Macro Economic Scenario
5. Global Hyperpigmentation Disorder Treatment Size and Growth
…..
32. Global Hyperpigmentation Disorder Treatment Competitive Benchmarking
33. Global Hyperpigmentation Disorder Treatment Competitive Dashboard
34. Key Mergers And Acquisitions In The Hyperpigmentation Disorder Treatment
35. Hyperpigmentation Disorder Treatment Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
